Development of Cardiovascular Implants Using Nanocomposite Polymer and Stem Cell Technology: From Lab to Commercialisation

Abstract:

Cardiovascular implants including bypass grafts, heart valves and stents are prone to thrombogenicity and mechanical incompatibility thus leading to limited graft patencies. Thus to overcome these issues, a nanocomposite polymer based on polyhedral oligomeric silsesquioxane (POSS) nanoparticles and poly(carbonate urea)urethane (PCU) has been developed and patented. A solvent exchange coagulation technique has been used in the fabrication of a compliant, POSS PCU graft. In addition, we present details of bonding of bioactive peptides to attract progenitor stem cells from peripheral circulating blood onto the implants and the endothelialisation potential on the lumen. Peptides are designed to enhance interactions with cell receptor integrins whilst and in-vitro and in-vivo tests are performed to determine both endothelial and platelet as well as whole blood interactions. In conclusion these results, together with its ease of manufacture and low cost, suggest that POSS-PCU nanocomposite could be an attractive material of choice for the development of cardiovascular implants.

• Periodical: Advances in Science and Technology (Volume 76)
• Pages: 207-213
• DOI: https://doi.org/10.4028/www.scientific.net/AST.76.207
• Online since: October 2010
• Authors: Alexander M. Seifalian, Achala de Mel, Hossein Ghanbari, Max Ahmed, Karla Chaloupka, Arnold Darbyshire
• Keywords: Cardiovascular, Nanocomposite Polymer, Nanomaterial, Polyhedral Oligosilsesquioxane (POSS), Stem Cells

References

[1] S. Allender, M. Rayner, and ., Coronary heart disease statistics; British Heart Foundation, (2007).

[2] S. Sarkar, T. Schmitz-Rixen, G. Hamilton, and A. M. Seifalian, Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review, Medical & Biological Engineering & Computing, vol. 45, no. 4, pp.327-336, (2007).

DOI: 10.1007/s11517-007-0176-z

[3] S. Sarkar, H. J. Salacinski, G. Hamilton, and A. M. Seifalian, The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency, Eur. J. Vasc. Endovasc. Surg., vol. 31, no. 6, pp.627-636, June2006.

DOI: 10.1016/j.ejvs.2006.01.006

[4] M. R. Hoenig, G. R. Campbell, and J. H. Campbell, Vascular grafts and the endothelium, Endothelium, vol. 13, no. 6, pp.385-401, Nov. (2006).

DOI: 10.1080/10623320601061615

[5] S. T. Rashid, B. Fuller, G. Hamilton, and A. M. Seifalian, Tissue engineering of a hybrid bypass graft for coronary and lower limb bypass surgery, FASEB J., Jan. (2008).

DOI: 10.1096/fj.07-096586

[6] H. J. Salacinski, N. R. Tai, G. Punshon, A. Giudiceandrea, G. Hamilton, and A. M. Seifalian, Optimal endothelialisation of a new compliant poly(carbonate-urea)urethane vascular graft with effect of physiological shear stress, European Journal of Vascular and Endovascular Surgery, vol. 20, no. 4, pp.342-352, (2000).

DOI: 10.1016/s1078-5884(00)91185-7

[7] J. M. Melero-Martin, Z. A. Khan, A. Picard, X. Wu, S. Paruchuri, and J. Bischoff, In vivo vasculogenic potential of human blood-derived endothelial progenitor cells, Blood, vol. 109, no. 11, pp.4761-4768, (2007).

DOI: 10.1182/blood-2006-12-062471

[8] C. Urbich and S. Dimmeler, Endothelial progenitor cells: characterization and role in vascular biology, Circ. Res., vol. 95, no. 4, pp.343-353, Aug. (2004).

DOI: 10.1161/01.res.0000137877.89448.78

[9] M. Jevon, A. Dorling, and P. I. Hornick, Progenitor cells and vascular disease, Cell Proliferation, vol. 41, pp.146-164, (2008).

DOI: 10.1111/j.1365-2184.2008.00488.x

[10] N. Alobaid, H. J. Salacinski, K. M. Sales, B. Ramesh, R. Y. Kannan, G. Hamilton, and A. M. Seifalian, Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: An in vitro evaluation, Eur J Vasc Endovasc Surg, vol. 32, no. 1, pp.76-83.

DOI: 10.1016/j.ejvs.2005.11.034

[11] A. de Mel, G. Jell, M. Stevens, and A. M. Seifalian, Biofunctionalisation of Biomaterials for Accelerated In-Situ Endothelialisation: A Review, (2008).

[12] N. Alobaid, H. J. Salacinski, K. M. Sales, B. Ramesh, R. Y. Kannan, G. Hamilton, and A. M. Seifalian, Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: An in vitro evaluation, Eur J Vasc Endovasc Surg, vol. 32, no. 1, pp.76-83.

DOI: 10.1016/j.ejvs.2005.11.034

[13] A. G. Kidane, G. Punshon, H. J. Salacinski, B. Ramesh, A. Dooley, M. Olbrich, J. Heitz, G. Hamilton, and A. M. Seifalian, Incorporation of a lauric acid-conjugated GRGDS peptide directly into the matrix of a poly(carbonate-urea)urethane polymer for use in cardiovascular bypass graft applications, J. Biomed. Mater. Res. A, vol. 79, no. 3, pp.606-617, Dec. (2006).

DOI: 10.1002/jbm.a.30817

[14] B. Krijgsman, A. M. Seifalian, H. J. Salacinski, N. R. Tai, G. Punshon, B. J. Fuller, and G. Hamilton, An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit versus conventional biological coatings: its role in enhancing cellular retention, Tissue Eng, vol. 8, no. 4, pp.673-680, Aug. (2002).

DOI: 10.1089/107632702760240580

[15] H. J. Salacinski, G. Hamilton, and A. M. Seifalian, Surface functionalization and grafting of heparin and/or RGD by an aqueous-based process to a poly(carbonate-urea)urethane cardiovascular graft for cellular engineering applications, J. Biomed. Mater. Res. A, vol. 66, no. 3, pp.688-697, Sept. (2003).

DOI: 10.1002/jbm.a.10020

[16] A. Tiwari, H. J. Salacinski, G. Punshon, G. Hamilton, and A. M. Seifalian, Development of a hybrid cardiovascular graft using a tissue engineering approach, FASEB J., vol. 16, no. 8, pp.791-796, June2002.

DOI: 10.1096/fj.01-0826com

[17] A. Tiwari, A. Kidane, H. Salacinski, G. Punshon, G. Hamilton, and A. M. Seifalian, Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate, Eur. J. Vasc. Endovasc. Surg., vol. 25, no. 4, pp.325-329, Apr. (2003).

DOI: 10.1053/ejvs.2002.1854

[18] R. Y. Kannan, H. J. Salacinski, P. E. Butler, and A. M. Seifalian, Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications, Acc. Chem. Res., vol. 38, no. 11, pp.879-884, Nov. (2005).

DOI: 10.1021/ar050055b

[19] R. Y. Kannan, H. J. Salacinski, M. Odlyha, P. E. Butler, and A. M. Seifalian, The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study, Biomaterials, vol. 27, no. 9, pp.1971-1979, Mar. (2006).

DOI: 10.1016/j.biomaterials.2005.10.006

[20] R. Y. Kannan, H. J. Salacinski, G. J. De, I. Clatworthy, L. Bozec, M. Horton, P. E. Butler, and A. M. Seifalian, The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite, Biomacromolecules., vol. 7, no. 1, pp.215-223, Jan. (2006).

DOI: 10.1021/bm050590z

[21] S. Sarkar, G. Burriesci, A. Wojcik, N. Aresti, G. Hamilton, and A. M. Seifalian, Manufacture of small calibre quadruple lamina vascular bypass grafts using a novel automated extrusion-phase-inversion method and nanocomposite polymer, J. Biomech., vol. 42, no. 6, pp.722-730, Apr. (2009).

DOI: 10.1016/j.jbiomech.2009.01.003

[22] H. J. Salacinski, S. Handcock, and A. M. Seifalian, Polymer for use in conduits and medical devices. Patent No.: WO2005070998: 2005, (2005).

[23] R. Y. Kannan, H. J. Salacinski, M. J. Edirisinghe, G. Hamilton, and A. M. Seifalian, Polyhedral oligomeric silsequioxane-polyurethane nanocomposite microvessels for an artificial capillary bed, Biomaterials, vol. 27, no. 26, pp.4618-4626, Sept. (2006).

DOI: 10.1016/j.biomaterials.2006.04.024

[24] S. Sarkar, G. Burriesci, A. Wojcik, N. Aresti, G. Hamilton, and A. M. Seifalian, Manufacture of small calibre quadruple lamina vascular bypass grafts using a novel automated extrusion-phase-inversion method and nanocomposite polymer, J. Biomech., vol. 42, no. 6, pp.722-730, Apr. (2009).

DOI: 10.1016/j.jbiomech.2009.01.003

[25] A. G. Kidane, M. J. Edirisinghe, P. Bonhoeffer, and A. M. Seifalian, Flow behaviour of a POSS biopolymer solution, Biorheology, vol. 44, no. 4, pp.265-272, (2007).

[26] J. D. Andrade and V. Hlady, Protein Adsorption and Materials Biocompatibility - A Tutorial Review and Suggested Hypotheses, Advances in Polymer Science, vol. 79, pp.1-63, (1986).

DOI: 10.1007/3-540-16422-7_6